Breast Oncology & Aesthetics Ltd

Breast Oncology & Aesthetics Ltd
Contents Page
For the Period 01 October 2024 to 31 October 2025

Company Information	1
Statement of Financial Position	2
Notes to the Financial Statements	3

Breast Oncology & Aesthetics Ltd
Company Information
For the Period 01 October 2024 to 31 October 2025

Director	Panagiotis Pikoulas
Registered Number	15991127
Registered Office	First Floor, 40 Vicarage Road Edgbaston Birmingham B15 3EZ
Accountants	Marneros Marcus & Co Limited First Floor Hagley Court 40 Vicarage Road Edgbaston Birmingham B153EZ

1

Registered Number: 15991127 Breast Oncology & Aesthetics Ltd
Statement of Financial Position
As at 31 October 2025

	Notes	2025 £
Fixed assets
Tangible fixed assets	3	762
		762
Current assets
Cash at bank and in hand		5,130
Creditors: amount falling due within one year	4	(2,734)
Net current assets		2,396

Total assets less current liabilities		3,158
Net assets		3,158

Capital and reserves
Called up share capital		100
Profit and loss account		3,058
Shareholders' funds		3,158

For the period ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the director on 01 July 2026 and were signed by:

-------------------------------
Panagiotis Pikoulas
Director

2

Breast Oncology & Aesthetics Ltd
Notes to the Financial Statements
For the Period 01 October 2024 to 31 October 2025

General Information

Breast Oncology & Aesthetics Ltd is a private company, limited by shares, registered in England and Wales, registration number 15991127, registration address First Floor, 40 Vicarage Road, Edgbaston, Birmingham, B15 3EZ.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Taxation

Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Fixtures and Fittings

25% Straight Line

2.	Average number of employees Average number of employees during the period was 2.

3.

Tangible fixed assets

Cost or valuation	Fixtures and Fittings	Total
	£	£
At 01 October 2024	-	-
Additions	1,016	1,016
Disposals	-	-
At 31 October 2025	1,016	1,016
Depreciation
At 01 October 2024	-	-
Charge for period	254	254
On disposals	-	-
At 31 October 2025	254	254
Net book values
Closing balance as at 31 October 2025	762	762
Opening balance as at 01 October 2024	-	-

4.

Creditors: amount falling due within one year

	2025 £
Trade Creditors	360
Corporation Tax	1,012
Directors' Current Accounts	1,362
	2,734

3

Registered Number: 15991127
England and Wales
BREAST ONCOLOGY & AESTHETICS LTD

Unaudited Financial Statements

Period of accounts Start date: 01 October 2024 End date: 31 October 2025